Best-in-class vs first-in-class
From First-in-class to Finest: How Best-in-Class Drugs Reshape Pharmaceutical Leadership
Semaglutide, tirzepatide, pembrolizumab and Zanubrutinib illustrate how best-in-class drugs surpass pioneers, with China’s $51.9B licensing deals driving worldwide pharmaceutical growth.